Konijnenberg, Lara S. F.
Zugwitz, Daša
Everaars, Henk
Hoeven, Nina W. van der
Demirkiran, Ahmet
Rodwell, Laura
van Leeuwen, Maarten A.H.
van Rossum, Albert C.
El Messaoudi, Saloua
Riksen, Niels P.
Royen, Niels van
Nijveldt, Robin
Funding for this research was provided by:
AstraZeneca
Ministerie van Economische Zaken
Article History
Received: 26 September 2022
Accepted: 19 November 2022
First Online: 9 December 2022
Change Date: 11 April 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s10554-023-02803-3
Statements & declarations
:
: D. Zugwitz acknowledges funding received from the European Society of Cardiology, Sophia Antipolis Cedex, France, in form of an ESC Training Grant. Prof. van Royen reports research grants from Astra Zeneca, Abbott, Philips, Biotronik and Top Sector Life Sciences & Health during the conduct of the study. Dr. van Leeuwen has received research grants from Astra Zeneca. Prof. Nijveldt has received research grants from Philips and Biotronik. All other authors have nothing to disclose.
: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the local Medical Ethics Review Committee VU University Medical Center Amsterdam.
: Written informed consent was obtained from all individual participants included in the study.
: 21 April 2015